E-LIB Suche - Ergebnisse für: Olugemo, Kemi

1

Conducting CNS trials during a public health emergency – Le..:

Olugemo, Kemi ; Bugarski-Kirola, Dragana ; Dawson, Gerard R....
Neuroscience Applied. 2 (2023) - p. 101129 , 2023

Link: https://doi.org/10.1016/..

2

Long-term efficacy and safety of inotersen for hereditary t..:

Brannagan, Thomas H. ; Coelho, Teresa ; Wang, Annabel K....
Journal of Neurology. 269 (2022) 12 - p. 6416-6427 , 2022

Link: https://doi.org/10.1007/..

3

Clinical and Epidemiological Characteristics of Patients wi..:

Khella, Sami ; Shah, Keyur ; Delgado, Diego...
Neurology. 96 (2021) 15_supplement - p. , 2021

Link: https://doi.org/10.1212/..

4

P007. Genotypic and Phenotypic Differences and Similarities..:

Keller, Andrew ; Akinboboye, Olakunle ; Delgado, Diego...
Heart & Lung. 50 (2021) 4 - p. 564 , 2021

Link: https://doi.org/10.1016/..

5

P008. Referral and Diagnosis of Hereditary Transthyretin Am..:

Bell, Christopher ; Dolinksy, Jill ; Gabriel, Aaron...
Heart & Lung. 50 (2021) 4 - p. 564-565 , 2021

Link: https://doi.org/10.1016/..

6

ATTR amyloidosis during the COVID-19 pandemic: insights fro..:

Brannagan III, Thomas H. ; Auer-Grumbach, Michaela ; Berk, John L....
Orphanet Journal of Rare Diseases. 16 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

7

Efficacy and safety with >3 years of inotersen treatment fo..:

Coelho, Teresa ; Whelan, Carol ; Conceição, Isabel...
Journal of the Neurological Sciences. 429 (2021) - p. 117867 , 2021

Link: https://doi.org/10.1016/..

8

Genotypic and Phenotypic Differences and Similarities Among..:

Keller, Andrew ; Shah, Keyur ; Delgado, Diego...
Journal of Cardiac Failure. 26 (2020) 10 - p. S84-S85 , 2020

Link: https://doi.org/10.1016/..

9

Patients with P.V142I Transthyretin Mutation: Insights from..:

Shah, Keyur ; Bumma, Naresh ; Delgado, Diego...
Journal of Cardiac Failure. 26 (2020) 10 - p. S84 , 2020

Link: https://doi.org/10.1016/..

10

P4‐014: PATIENT‐CENTRIC PROTOCOL OPTIMIZATION IN AD TRIALS:

Olugemo, Kemi
Alzheimer's & Dementia. 15 (2019) 7S_Part_24 - p. , 2019

Link: https://doi.org/10.1016/..

11

P3‐014: WILLINGNESS TO PARTICIPATE IN CLINICAL TRIALS IS NO..:

Park, Lovingly ; Mendoza, Zyanya ; Lee, Sophie...
Alzheimer's & Dementia. 15 (2019) 7S_Part_18 - p. , 2019

Link: https://doi.org/10.1016/..

12

CROs and CNS research: challenges and trends:

Olugemo, Kemi
Drug Discovery Today. 23 (2018) 6 - p. 1167-1168 , 2018

Link: https://doi.org/10.1016/..

13

Pharmacokinetic Properties and Tolerability of Low-dose Sol..:

Desjardins, Paul J. ; Olugemo, Kemi ; Solorio, Daniel.
Clinical Therapeutics. 37 (2015) 2 - p. 448-461 , 2015

Link: https://doi.org/10.1016/..

14

Long-term efficacy and safety of inotersen for hereditary t..:

Brannagan, Thomas H ; Coelho, Teresa ; Wang, Annabel K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618524/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Long-term efficacy and safety of inotersen for hereditary t..:

Brannagan, Thomas H ; Coelho, Teresa ; Wang, Annabel K...
https://www.springer.com/journal/415. , 2022

Link: http://hdl.handle.net/10..